Literature DB >> 15025429

Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis.

S Grosso1, M A Margollicci, E Bargagli, Q R Buccoliero, A Perrone, D Galimberti, G Morgese, P Balestri, P Rottoli.   

Abstract

BACKGROUND: Sarcoidosis is a systemic granulomatous disease characterized by T-lymphocyte activation and lymphocyte migration into involved organs, usually the lungs. The amounts of a number of biochemical markers, such as angiotensin converting enzyme (ACE) activity, increase in the serum of patients with sarcoidosis. Chitotriosidase is an enzyme secreted by activated macrophages able to catalyze the hydrolysis of both chitin and chitin-like substrates. Chitotriosidase is involved in defense against, and in degradation of chitin-containing pathogens such as fungi, nematodes, and insects.
METHODS: Forty-three patients affected by chronic sarcoidosis, in active (23 patients) or inactive (20 patients) phase, were studied. Serum levels of chitotriosidase and ACE activity were evaluated and compared with those of 32 healthy subjects. Serum chitotriosidase concentration and ACE activity were also correlated with radiographic stage of disease.
RESULTS: Individuals with chronic sarcoidosis have higher serum chitotriosidase concentrations and ACE activity than those of normal subjects. Sarcoidosis patients in the active phase of the disease had significantly higher chitotriosidase and ACE levels than those in the inactive phase. In contrast to serum ACE activity, a significant relationship between serum levels of chitotriosidase and the four radiographic stages of the disease was observed.
CONCLUSION: Although the data need to be validated by further investigation, the observations made in this study seem to indicate that serum chitotriosidase concentrations may be a useful marker for monitoring sarcoidosis disease activity and prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025429     DOI: 10.1080/00365510410004092

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  11 in total

1.  Serum chitotriosidase activity in sarcoidosis patients.

Authors:  Elena Bargagli; Paola Rottoli
Journal:  Rheumatol Int       Date:  2007-08-21       Impact factor: 2.631

2.  Human chitotriosidase: a sensitive biomarker of sarcoidosis.

Authors:  Elena Bargagli; David Bennett; Claudia Maggiorelli; Pasquale Di Sipio; Maria Margollicci; Nicola Bianchi; Paola Rottoli
Journal:  J Clin Immunol       Date:  2012-08-10       Impact factor: 8.317

3.  Evaluation of Circulating Chitotriosidase Activity in Children with Obesity.

Authors:  Ioana Țaranu; Mihaela Iancu; Cecilia Lazea; Camelia Alkhzouz; Nicoleta Răcătăianu; Cristina-Sorina Cătană; Andreea-Manuela Mirea; Diana Miclea; Sorana D Bolboacă; Cristina Drugan
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

4.  Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.

Authors:  Julia Kzhyshkowska; Alexei Gratchev; Sergij Goerdt
Journal:  Biomark Insights       Date:  2007-05-03

Review 5.  The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases.

Authors:  Carole Ober; Geoffrey L Chupp
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10

Review 6.  Chitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPD.

Authors:  Soo Jung Cho; Michael D Weiden; Chun Geun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-11-05       Impact factor: 5.764

Review 7.  Catch the rainbow: Prognostic factor of sarcoidosis.

Authors:  Senol Kobak
Journal:  Lung India       Date:  2020 Sep-Oct

8.  Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment and correlations with clinical parameters.

Authors:  Gulhan Cakır; Seyfettin Gumus; Ergun Ucar; Hatice Kaya; Ergun Tozkoparan; Emin Ozgur Akgul; Bulent Karaman; Omer Deniz; Ismail Kurt; Metin Ozkan; Hayati Bilgic
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

9.  Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?

Authors:  Nadira Duraković; Ivan Krečak; Zinaida Perić; Milan Milošević; Lana Desnica; Dražen Pulanić; Iskra Pusic; Vesna Kušec; Radovan Vrhovac; Steven Z Pavletic; Damir Nemet
Journal:  Croat Med J       Date:  2016-06-30       Impact factor: 1.351

10.  Verifying Sarcoidosis Activity: Chitotriosidase versus ACE in Sarcoidosis - a Case-control Study.

Authors:  Spasoje Popević; Zorica Šumarac; Dragana Jovanović; Dragan Babić; Mihailo Stjepanović; Snežana Jovičić; Dragana Šobić-Šaranović; Snežana Filipović; Branko Gvozdenović; Maja Omčikus; Anđela Milovanović; Jelica Videnović-Ivanov; Ana Radović; Vladimir Žugić; Violeta Mihailović-Vučinić
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.